Keepan A Spray
NDC Package 49873-019-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Keepan A (benzalkonium chloride, lidocaine hydrochloride) sprays is uses  First aid for minor cuts, scrapes and burns:■ to help reduce the risk of infection■ for the temporary relief of pain and itching. This formulation utilizes a spray delivery system. Marketed by Sato Pharmaceutical Co., Ltd., this product is identified by NDC 49873-019 and is authorized under FDA application M003.

Identification & Billing

NDC Package Code
49873-019-01
Package Description
1 BOTTLE, SPRAY in 1 CARTON / 60 mL in 1 BOTTLE, SPRAY
Product Code
11-Digit Billing Format
49873001901
RxNorm Crosswalk
  • RxCUI: 1246623 - benzalkonium chloride 0.1 % / lidocaine HCl 1 % Topical Spray
  • RxCUI: 1246623 - benzalkonium chloride 1 MG/ML / lidocaine hydrochloride 10 MG/ML Topical Spray
  • RxCUI: 1246623 - benzalkonium chloride 0.1 % / lidocaine hydrochloride 1 % Topical Spray
  • RxCUI: 1246628 - KEEPAN A 0.1 % / 1 % Topical Spray
  • RxCUI: 1246628 - benzalkonium chloride 1 MG/ML / lidocaine hydrochloride 10 MG/ML Topical Spray [Keepan]

Clinical Specifications

Proprietary Name
Keepan A
Non-Proprietary Name
Benzalkonium Chloride, Lidocaine Hydrochloride
Substance Name
Benzalkonium Chloride; Lidocaine Hydrochloride
Dosage Form
Spray - A liquid minutely divided as by a jet of air or steam.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Usage Information
Uses  First aid for minor cuts, scrapes and burns:■ to help reduce the risk of infection■ for the temporary relief of pain and itching

Regulatory & Marketing

Labeler Name
Sato Pharmaceutical Co., Ltd.
Product Type
Human Otc Drug
FDA Application #
M003
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
07-15-1981
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 49873-019-01 identifies a specific commercial package of 1 bottle, spray in 1 carton / 60 ml in 1 bottle, spray of Keepan A, a human over the counter drug labeled by Sato Pharmaceutical Co., Ltd.. This spray is formulated for topical use and contains benzalkonium chloride; lidocaine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sato Pharmaceutical Co., Ltd. on July 15, 1981. The current certification is valid through December 31, 2026.

How is this Sato Pharmaceutical Co., Ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 49873001901. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
49873-019-01
11-Digit CMS (5-4-2)
49873-0019-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.